Evidence map›Paper›PMID 34259395›Full record

ArticleChemSusChem2021

β-Zeolite-Assisted Lignin-First Fractionation in a Flow-Through Reactor*.

Alexei Kramarenko, Deniz Etit, Gabriele Laudadio, Fernanda Neira D'Angelo

Open access · hybridAbstract read
In one paragraph

Article in ChemSusChem, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Alexei KramarenkoDepartment of Chemical Engineering and Chemistry, Eindhoven University of Technology, Het Kranenveld 14, 5612 AZ, Eindhoven, The Netherlands.
Deniz EtitDepartment of Chemical Engineering and Chemistry, Eindhoven University of Technology, Het Kranenveld 14, 5612 AZ, Eindhoven, The Netherlands.
Gabriele LaudadioDepartment of Chemical Engineering and Chemistry, Eindhoven University of Technology, Het Kranenveld 14, 5612 AZ, Eindhoven, The Netherlands.
Fernanda Neira D'AngeloDepartment of Chemical Engineering and Chemistry, Eindhoven University of Technology, Het Kranenveld 14, 5612 AZ, Eindhoven, The Netherlands.
Eindhoven University of Technology · NLScripps Research Institute · US

Funding

GPC analyses
6 · The paper itself

Abstract

In the present work, a hydrogen-free one-step catalytic fractionation of woody biomass using commercial β-zeolite as catalyst in a flow-through reactor was carried out. Birch, spruce, and walnut shells were compared as lignocellulosic feedstocks. β-Zeolite acted as a bifunctional catalyst, preventing lignin repolymerization due to its size-selective properties and also cleaving β-O-4 lignin intralinkages while stabilizing reactive intermediates. A rate-limiting step analysis using different reactor configurations revealed a mixed regime where the rates of both solvolytic delignification and zeolite-catalyzed depolymerization and dehydration affected the net rate of aromatic monomer production. Oxalic acid co-feeding was found to enhance monomer production at moderate concentrations by improving solvolysis, while it caused structural changes to the zeolite and led to lower monomer yields at higher concentrations. Zeolite stability was assessed through catalyst recycling and characterization. Main catalyst deactivation mechanisms were found to be coking and leaching, leading to widening of the pores and decrease of zeolite acidity, respectively.

Indexed as

depolymerizationflow-throughligninlignocellulosezeolites

Identifiers

PMID34259395
PMCPMC8518628
OpenAlexW3137056468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.